Dementia, Mild
53
11
17
23
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
3.8%
2 terminated out of 53 trials
92.0%
+5.5% vs benchmark
6%
3 trials in Phase 3/4
13%
3 of 23 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 23 completed trials
Clinical Trials (53)
A Pivotal Study of Sensory Stimulation in Alzheimer's Disease (HOPE Study)
Decision Making Tool for Firearm Storage
Effect of 10 mg Xanamem on Dementia Due to Alzheimer's Disease
Identify the Benefits CAREGIVERSPRO-MMD Platform Use Based on the Information and Communications Technology, Dedicated to the Support and Assistance of Dyads Living With Neurocognitive Diseases and Their Primary Caregivers
Cognitive Stimulation Therapy for Dementia: A Two-Armed Pragmatic Trial
Development of Pressure Sensor Based Dementia and Fall Prevention Program for Older Adults
GLP-1/GCG Dual Agonist in Type 2 Diabetes With Early Dementia (LIGHT-COG Study)
Precision Medicine Approach for Early Dementia & Mild Cognitive Impairment
Cognitive Screening Made Easy for PCPs - R33 Phase
Cognitive Screening Made Easy for PCPs - Administrative Supplement
FitMi AD Home Therapy for Individuals With MCI or Mild Dementia Due to Alzheimer's Disease
Family Caregiver Online Survey (Dementia and Swallowing Difficulties)
Event-Related Potential (ERP) Components in Clinical Diagnosis
Pain With Dementia
The Brain Health Champion Study
Tau PET Outcomes With Anti-amyloid Immunotherapies
Adaptation of the Uniform Data Set for Telematic Administration
Autonomic Involvement in Patient With Cognitive Decline
Buddy-Up Dyadic Physical Activity Program for Persons With Dementia and Family Caregivers
The "Let's Talk Tech" Tool to Support Decision Making About Technology Use